We are evaluating the safety and tolerability of a new gene therapy for patients with rod cone dystrophy. This study aims to understand how well the treatment is tolerated in this specific group.
Health conditions and diseases that the clinical trial is designed to study and treat.
Hereditary retinal dystrophy refers to a group of genetic disorders that cause progressive degeneration of the retina, leading to vision loss. These conditions are often inherited and can result in symptoms such as night blindness, loss of peripheral vision, and eventual loss of central vision.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.